Acotec Scientific Holdings (HKSE:06669) Tax Expense: HK$2.6 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06669 Acotec Scientific Holdings Ltd HKSE:06669
76 GF Score
Price HK$6.24
GF Value HK$14.84
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Acotec Scientific Holdings Tax Expense?

Acotec Scientific Holdings HKSE:06669 -1.96% 76 Tax Expense is HK$2.6 Mil as of Dec. 2025. GuruFocus rates HKSE:06669 with a GF Score™ of 76/100 and a GF Value™ of HK$14.84 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Acotec Scientific Holdings's tax expense for the months ended in Dec. 2025 was HK$2.3 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2.6 Mil.


Acotec Scientific Holdings  (HKSE:06669) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Acotec Scientific Holdings Tax Expense Related Terms


Acotec Scientific Holdings Tax Expense Historical Data

* Premium members only.

The historical data trend for Acotec Scientific Holdings's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acotec Scientific Holdings Tax Expense Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
Get a 7-Day Free Trial 14.49 0.20 -0.04 0.34 3.31

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 0.36 1.00 2.30 0.31
HKSE:06669
76GF Score
Acotec Scientific Holdings Ltd HKSE:06669
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acotec Scientific Holdings Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$2.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of HK$2.6 Mil mean?
Acotec Scientific Holdings (HKSE:06669) has a Tax Expense of HK$2.6 Mil as of Dec. 2025. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Acotec Scientific Holdings and its competitors.
Is Acotec Scientific Holdings' Tax Expense too high?
Acotec Scientific Holdings' current Tax Expense is HK$2.6 Mil. Overall, Acotec Scientific Holdings has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acotec Scientific Holdings' Tax Expense compare to ABT and SYK?
Acotec Scientific Holdings' Tax Expense of HK$2.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Devices & Instruments company?
A good Tax Expense depends on the Medical Devices & Instruments industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Acotec Scientific Holdings and its competitors. Acotec Scientific Holdings's current Tax Expense is HK$2.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acotec Scientific Holdings stock overvalued right now?
Based on GuruFocus' analysis, Acotec Scientific Holdings (HKSE:06669) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.84, compared to a current price of HK$6.24 — trading 58% below its estimated fair value. The current Tax Expense is HK$2.6 Mil. Acotec Scientific Holdings' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Acotec Scientific Holdings (HKSE:06669), the current Tax Expense is HK$2.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acotec Scientific Holdings (HKSE:06669) Overvalued in 2026?

Based on GuruFocus' analysis, Acotec Scientific Holdings stock appears to be undervalued. The current stock price of HK$6.24 is trading 58% below its estimated GF Value™ of HK$14.84. GuruFocus considers Acotec Scientific Holdings to be Significantly Undervalued.

Key valuation signals for HKSE:06669:

  • Tax Expense: HK$2.6 Mil
  • GF Value™: HK$14.84 vs. price of HK$6.24 (58% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the HKSE:06669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Acotec Scientific Holdings Business Description

Other Exchanges 7W3:Germany
Address 16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions. The firm generates the majority of its revenue from sales to Domestic distributors.
76GF Score

Get the complete analysis for HKSE:06669

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.24
Price
HK$14.84
GF Value